Elin Electronics Ltd IPO

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Here’s the consolidated financial information for the last three years:

• Established market position in key verticals including leadership in fractional horsepower motors;
• Diversified products resulting in a de-risked business model;
• Entrenched relationships with a marquee customer base;
• High degree of backward integration resulting in higher efficiencies, enhanced quality of products and customer retention capability;
• Consistent and strong track record of financial performance.

• The company is highly dependent on certain key customers for a substantial portion of its revenues. Loss of relationship with any of these customers may have a material adverse effect on its profitability and results of operations.
• The COVID-19 pandemic, or a similar public health threat, could adversely affect its business, financial condition and results of operations.
• The company do not obtain firm and long-term volume purchase commitments from its customers. If its customers choose not to renew their agreements with it or continue to place orders with it, the company business and results of operations will be adversely affected.
• Its manufacturing facilities are critical to its business. Any disruption in the continuous operations of its manufacturing facilities would have a material adverse effect on its business, results of operations and financial condition.
• Its business and results of operations are dependent on the contracts that the company enter into. Any breach of the conditions under these contracts may adversely affect its business and results of operations.

• Enhance customer base and relationships through cross-selling and product development
• Expand ODM share of the business
• Augmenting its R&D capabilities
• Expanding operations in medical diagnostics cartridges and manufacturing facilities
• Focus on one-stop-shop facility with increased degree of backward integration